Related Experiment Video
Updated: May 12, 2026
08:02
Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
13.0K
Engineered carbon dots for mucosal gene delivery.
Samuel Arca1, Françoise Pons1, Luc Lebeau1
1Laboratoire de Chémo-Biologie Synthétique et Thérapeutique, UMR 7199 CNRS-Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin 67400 Illkirch, France.
Summary
Researchers developed mucus-penetrating gene carriers using carbon dots (CDs) to overcome airway mucus barriers for lung gene therapy. Mucolytic-acting CDs significantly improved DNA delivery to lung epithelial cells, offering a promising therapeutic strategy.
Area of Science:
- Biomaterials Science
- Gene Therapy
- Nanotechnology
Background:
- Lung gene therapy faces challenges due to the airway mucus layer, which impedes efficient gene delivery.
- Mucociliary clearance rapidly removes therapeutic particles before they reach target epithelial cells.
- Developing mucus-penetrating gene carriers is crucial for effective lung gene therapy.
Purpose of the Study:
- To engineer novel mucus-penetrating gene carriers based on carbon dots (CDs).
- To evaluate strategies for rendering CDs muco-inert, including PEGylation and zwitterionic/mucolytic modifications.
- To assess the efficacy of these modified CDs in delivering DNA through mucus to lung cells.
Main Methods:
- Synthesized carbon dots (CDs) from citric acid and bPEI600.
- Modified CDs with PEG, zwitterionic, or mucolytic species to enhance mucus penetration.
- Assessed carrier-mucus interactions using turbidimetry, transport measurements, and rheology.
- Evaluated DNA delivery efficiency in cell models, including Calu-3 cells cultured at the air-liquid interface.
Main Results:
- CDs modified with mucolytic agents (thiol reservoirs) demonstrated superior mucus penetration and DNA delivery.
- PEGylated CDs showed moderate gene transfection, while zwitterion-coated CDs were largely ineffective.
- The air-liquid interface Calu-3 cell model effectively discriminated the performance of different CD formulations.
Conclusions:
- Carbon dot-based gene carriers, particularly those with mucolytic properties, can effectively penetrate airway mucus.
- This approach significantly enhances gene delivery to lung epithelial cells, overcoming a major hurdle in lung gene therapy.
- Mucolytic-acting carbon dots represent a promising strategy for developing advanced lung gene delivery systems.
